Mesoblast Ltd (ASX:MSB)
A$ 2.41 +0.050 (+2.12%) Market Cap: 3.06 Bil Enterprise Value: 3.07 Bil PE Ratio: 9,999.00 PB Ratio: 3.36 GF Score: 39/100

Full Year 2020 Mesoblast Ltd Earnings Presentation Transcript

Aug 26, 2020 / 10:00PM GMT
Release Date Price: A$4.88 (-1.72%)

Aug 26, 2020 / 10:00PM GMT
Presentation
Aug 26, 2020 / 10:00PM GMT

=====================
Corporate Participants
=====================
* Fred Grossman
Mesoblast Limited - Chief Medical Officer
* Josh Muntner
Mesoblast Limited - CFO
* Silviu Itescu
Mesoblast Limited - Founder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director

=====================
Conference Call Participants
=====================
* Jason Howard Kolbert
Dawson James Securities, Inc., Research Division - Director of Research
* Jeffrey Scott Cohen
Ladenburg Thalmann & Co. Inc., Research Division - MD of Equity Research
* Louise Alesandra Chen
Cantor Fitzgerald & Co., Research Division - Senior Research Analyst & MD
* Swayampakula Ramakanth
H.C. Wainwright & Co, LLC, Research Division - MD of Equity Research & Senior Healthcare Analyst
* Tanushree Jain
Bell Potter Securities Limited, Research Division - Healthcare and Biotech Analyst

=====================
Operator<

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot